Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides

Daniel J. Lewis, Madeleine Duvic

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Extracorporeal photopheresis (ECP) has been used for nearly 30 years in the treatment of cutaneous T-cell lymphoma. However, current clinical practice largely reserves ECP for patients with late-stage mycosis fungoides (MF) or Sézary syndrome or for those who are refractory to other therapies. We briefly describe a 48-year-old male who experienced long-term complete remission of his patch MF disease with ECP, and we suggest a role for ECP in the treatment of early-stage MF given evidence of its efficacy, safety, and tolerability.

Original languageEnglish (US)
Article numbere12485
JournalDermatologic Therapy
Volume30
Issue number3
DOIs
StatePublished - May 1 2017

Keywords

  • Mycosis fungoides
  • Sézary syndrome
  • early stage
  • extracorporeal photopheresis

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides'. Together they form a unique fingerprint.

Cite this